Developer docs
API playgroundTry for free, no card

Search company profiles

Dedimo

Full company profile

uuid0048vmb

Namestring
Dedimo
Legal namestring
Dedimo B.V.
Websiteurl
dedimo.nl
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Dedimo B.V. is a privately held Dutch mental healthcare holding company founded in 2020 and headquartered at Janskerkhof 16 in Utrecht. It operates a portfolio of five wholly-owned, specialized healthcare subsidiaries — ADHDcentraal (adult ADHD diagnosis and treatment), ADHDcentraal Jeugd (ADHD care for children and adolescents), WPEX (psychiatric, neuropsychological and insurance-medicine expert examinations), QSG (diagnosis, treatment and reintegration for psychological absenteeism under the ARBO occupational-health framework), and The Brain Hub (organizational consulting to help employers support neurodivergent employees). The portfolio is supported by a central staff function covering HR, finance, IT, operations, marketing, recruiting, quality systems and data science, and by an in-house Research & Development unit that conducts scientific research on treatment effectiveness and develops custom ICT applications to support care processes. The company is led by a four-person executive board — CEO Jan Willem Peterse, CFO Michiel de Jong, and Director of Innovation & Strategy Jan-Eidse van Melle — with no disclosed external investors, funding rounds, or parent company.

The business operates as a B2B2C healthcare services provider. Patient access comes through Dutch GP referrals, mandatory health-insurance (zorgverzekering) reimbursement for clinical services, and employer/ARBO channels for occupational-health and reintegration work. Patient-facing subsidiaries offer combined in-person and video consultations; employer-facing subsidiaries (WPEX, QSG, The Brain Hub) distribute through employer relationships, occupational-health insurers, and insurance-medicine channels. Pricing is not publicly disclosed and services are reimbursed primarily via the Dutch mandatory health-insurance system. Revenue mechanics are therefore recurring and reimbursement-driven rather than transactional. Geographic scope is the Netherlands only, with no international expansion disclosed.

The technology layer is internal and proprietary but not publicly detailed: Dedimo R&D develops custom ICT applications to optimize care pathways and protocol effectiveness, supported by a small in-house data-science team. No APIs, SDKs, third-party AI integrations, or patents are disclosed. The central staff model — combining HR, finance, IT, marketing, data science, quality systems and R&D across five clinical brands — is the company's principal operating asset and supports both cost sharing across subsidiaries and a continuous-improvement loop on treatment protocols.

Short descriptiontext

Dedimo is a Dutch mental healthcare holding founded in 2020 that operates five specialized subsidiaries — adult ADHD, youth ADHD, insurance-medicine examinations, ARBO reintegration, and neurodiversity workplace consulting — reimbursed primarily through Dutch health insurance and employer channels, supported by a central staff and in-house R&D unit.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersUtrecht, Netherlands
HQ citystring
Utrecht
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mental healthcare services, ADHD treatment, occupational health services, psychiatric examinations, workplace reintegration
Industry3 codes
1Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching)
CodeHLALAEAJPrimaryYes
2Psychiatry & Medication Management Platforms
CodeHLALAEABPrimaryNo
3Behavioral Health & Psychiatry Virtual Care (Payer Network)
CodeHLALACACPrimaryNo
NAICS code3 codes
  • Offices of Physicians, Mental Health Specialists621112
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Offices of Mental Health Practitioners (except Physicians)621330
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Misc Health & Allied Services, Nec8090
Product category
Mental Healthcare Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Mental Healthcare Services Revenue
TypeSubscription Recurring
Description

Dedimo generates revenue through the delivery of mental healthcare services across its five subsidiary brands. Services are reimbursed through Dutch health insurance (zorgverzekering) and occupational health (ARBO) channels. The portfolio covers ADHD diagnosis/treatment for adults and youth, psychiatric assessments, psychological absenteeism diagnosis/treatment/reintegration, and neurodivergent workplace support.

dedimo.nl
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Dedimo is a Dutch healthcare innovation company operating a portfolio of five specialized mental healthcare subsidiaries: ADHDcentraal (adult ADHD diagnosis and treatment), ADHDcentraal Jeugd (youth ADHD diagnosis and treatment), WPEX (psychiatric neuropsychological and insurance medical expert examinations), QSG (diagnosis, treatment and reintegration for psychological absenteeism under ARBO frameworks), and The Brain Hub (neurodivergent workplace transformation consulting). Services are delivered through specialized clinics supported by a central staff providing HR, finance, ICT, marketing, data science, and R&D functions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Minimized patient wait times
Product overview1 text field

Dedimo is a portfolio company comprising five mental healthcare initiatives, established in 2020. The portfolio includes ADHDcentraal (adult ADHD treatment), ADHDcentraal Jeugd (youth ADHD treatment), WPEX (psychiatric neuropsychological examinations), QSG (psychological absenteeism reintegration), and The Brain Hub (neurodiversity workplace support). These initiatives are centrally supported by Dedimo Central Staff (HR, finance, operations, marketing, ICT, data science) and Dedimo Research & Development, which conducts scientific research and develops ICT applications to optimize care processes.

Product and service5 records
1ADHDcentraal
CategoryAdult ADHD treatment services
Description

Knowledge and treatment center for ADHD in adults, providing specialized psychiatric care, diagnosis, and treatment services. Targets adult patients seeking ADHD assessment and ongoing care, with combined in-person and video consultation options.

2ADHDcentraal Jeugd
CategoryYouth AD(H)D treatment services
Description

Knowledge and treatment center for AD(H)D in children and adolescents, offering specialized youth mental health services with family-centered care and combined consultation options to minimize disruption.

3WPEX
CategoryExpert examination services
Description

Provides psychiatric, neuropsychological, and insurance medical expert examinations for employers, occupational health services, and insurance companies. Supports objective expert assessments required for occupational health decisions and insurance claims.

4QSG
CategoryOccupational health reintegration services
Description

Provides diagnosis, treatment, and reintegration services for employees with psychological absenteeism under ARBO (occupational health) frameworks. Helps employers reduce absenteeism costs and comply with occupational health regulations.

5The Brain Hub
CategoryNeurodiversity workplace consulting
Description

Helps employees with neurodivergent brains excel by guiding organizations through transformation toward a healthy and inclusive work environment. Provides consulting on organizational change, neurodivergent employee retention, and inclusive workplace culture.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dedimo R&D collaborates with external institutions and universities on research projects, supporting the individual subsidiaries' research objectives and contributing to product development. Specific partner names and dates are not publicly disclosed.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Dutch digital mental health platform providing e-mental health tools and patient-clinician portals to GGZ providers. Comparable to Dedimo R&D's custom ICT applications and Dedimo's broader digital health tooling strategy, as an enabling technology peer rather than direct clinical competitor.

TypeBroad incumbent
Description

Largest Dutch ARBO/occupational health service provider, part of HumanTotalCare. Directly comparable to Dedimo's QSG psychological absenteeism reintegration and The Brain Hub workplace neurodiversity consulting via the same employer/ARBO channel.

TypeEmerging player
Description

US telehealth platform offering therapy and psychiatry via video/text to insurers and employers. Comparable to Dedimo's hybrid mental healthcare delivery model and payer-channel revenue structure, though operating in the US market.

4Interapy
TypeDirect peer
Description

Dutch online therapy provider offering reimbursed mental healthcare through internet-based protocols. Comparable to Dedimo's ADHDcentraal and QSG lines via the same Dutch health-insurance reimbursement channel and behavioral therapy focus.

TypeEmerging player
Description

European digital mental health platform serving employers and employees across multiple countries. Comparable to Dedimo's The Brain Hub B2B employer channel and ADHDcentraal's digital-first delivery model, though operating pan-Europe rather than Netherlands-only.

TypeEmerging player
Description

US mental health benefits platform for employers offering therapy, coaching and psychiatry. Comparable to Dedimo's The Brain Hub and QSG B2B employer services targeting workplace mental health and absenteeism reduction.

TypeDirect peer
Description

Swedish-founded digital mental health platform that operates in the Netherlands, offering video-based therapy and psychiatry with insurance reimbursement. Directly comparable to Dedimo's hybrid in-person + video mental health delivery model.

TypeBroad incumbent
Description

Largest Dutch chain of mental healthcare clinics, part of Parnassia Groep, offering specialized outpatient GGZ across multiple conditions. Comparable to Dedimo as a Netherlands-based specialty mental healthcare operator, though with broader condition coverage and larger scale.

TypeDirect peer
Description

Dutch psychology practice network offering online and in-person mental healthcare reimbursed by Dutch insurers. Comparable to ADHDcentraal and ADHDcentraal Jeugd as a reimbursed outpatient mental healthcare provider in the Netherlands.

TypeBroad incumbent
Description

Global digital mental health platform combining meditation, coaching and therapy. Comparable to Dedimo's employer-facing The Brain Hub and broader mental healthcare portfolio, though at much larger scale and B2B employer-first go-to-market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dedimo

Mental Healthcare Servicesdedimo.nl

Dedimo is a Dutch mental healthcare holding founded in 2020 that operates five specialized subsidiaries — adult ADHD, youth ADHD, insurance-medicine examinations, ARBO reintegration, and neurodiversity workplace consulting — reimbursed primarily through Dutch health insurance and employer channels, supported by a central staff and in-house R&D unit.

What Dedimo does

Dedimo B.V. is a privately held Dutch mental healthcare holding company founded in 2020 and headquartered at Janskerkhof 16 in Utrecht. It operates a portfolio of five wholly-owned, specialized healthcare subsidiaries — ADHDcentraal (adult ADHD diagnosis and treatment), ADHDcentraal Jeugd (ADHD care for children and adolescents), WPEX (psychiatric, neuropsychological and insurance-medicine expert examinations), QSG (diagnosis, treatment and reintegration for psychological absenteeism under the ARBO occupational-health framework), and The Brain Hub (organizational consulting to help employers support neurodivergent employees). The portfolio is supported by a central staff function covering HR, finance, IT, operations, marketing, recruiting, quality systems and data science, and by an in-house Research & Development unit that conducts scientific research on treatment effectiveness and develops custom ICT applications to support care processes. The company is led by a four-person executive board — CEO Jan Willem Peterse, CFO Michiel de Jong, and Director of Innovation & Strategy Jan-Eidse van Melle — with no disclosed external investors, funding rounds, or parent company.

The business operates as a B2B2C healthcare services provider. Patient access comes through Dutch GP referrals, mandatory health-insurance (zorgverzekering) reimbursement for clinical services, and employer/ARBO channels for occupational-health and reintegration work. Patient-facing subsidiaries offer combined in-person and video consultations; employer-facing subsidiaries (WPEX, QSG, The Brain Hub) distribute through employer relationships, occupational-health insurers, and insurance-medicine channels. Pricing is not publicly disclosed and services are reimbursed primarily via the Dutch mandatory health-insurance system. Revenue mechanics are therefore recurring and reimbursement-driven rather than transactional. Geographic scope is the Netherlands only, with no international expansion disclosed.

The technology layer is internal and proprietary but not publicly detailed: Dedimo R&D develops custom ICT applications to optimize care pathways and protocol effectiveness, supported by a small in-house data-science team. No APIs, SDKs, third-party AI integrations, or patents are disclosed. The central staff model — combining HR, finance, IT, marketing, data science, quality systems and R&D across five clinical brands — is the company's principal operating asset and supports both cost sharing across subsidiaries and a continuous-improvement loop on treatment protocols.

Dedimo firmographics

Firmographics
Name
Dedimo
Legal name
Dedimo B.V.
Website
https://dedimo.nl
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Dedimo is a Dutch mental healthcare holding founded in 2020 that operates five specialized subsidiaries — adult ADHD, youth ADHD, insurance-medicine examinations, ARBO reintegration, and neurodiversity workplace consulting — reimbursed primarily through Dutch health insurance and employer channels, supported by a central staff and in-house R&D unit.
Ownership category
akta.pro rank

Dedimo industry classification

Industry
Product category
Mental Healthcare Services
NAICS
Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Mental Health Practitioners (except Physicians) (621330)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching) (HLALAEAJ)
akta.pro secondary industries
Psychiatry & Medication Management Platforms (HLALAEAB), Behavioral Health & Psychiatry Virtual Care (Payer Network) (HLALACAC)

Keywords

  • Mental healthcare services
  • ADHD treatment
  • Occupational health services
  • Psychiatric examinations
  • Workplace reintegration

Where Dedimo is headquartered

Location

Headquarters

HQ city
Utrecht
HQ country
Netherlands
HQ region
Europe

Offices2 records

Markets served

Dedimo business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Mental Healthcare Services Revenue: Dedimo generates revenue through the delivery of mental healthcare services across its five subsidiary brands. Services are reimbursed through Dutch health insurance (zorgverzekering) and occupational health (ARBO) channels. The portfolio covers ADHD diagnosis/treatment for adults and youth, psychiatric assessments, psychological absenteeism diagnosis/treatment/reintegration, and neurodivergent workplace support.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Dedimo product offering

Product offering

Core offering

Dedimo is a Dutch healthcare innovation company operating a portfolio of five specialized mental healthcare subsidiaries: ADHDcentraal (adult ADHD diagnosis and treatment), ADHDcentraal Jeugd (youth ADHD diagnosis and treatment), WPEX (psychiatric neuropsychological and insurance medical expert examinations), QSG (diagnosis, treatment and reintegration for psychological absenteeism under ARBO frameworks), and The Brain Hub (neurodivergent workplace transformation consulting). Services are delivered through specialized clinics supported by a central staff providing HR, finance, ICT, marketing, data science, and R&D functions.

Product overview

Dedimo is a portfolio company comprising five mental healthcare initiatives, established in 2020. The portfolio includes ADHDcentraal (adult ADHD treatment), ADHDcentraal Jeugd (youth ADHD treatment), WPEX (psychiatric neuropsychological examinations), QSG (psychological absenteeism reintegration), and The Brain Hub (neurodiversity workplace support). These initiatives are centrally supported by Dedimo Central Staff (HR, finance, operations, marketing, ICT, data science) and Dedimo Research & Development, which conducts scientific research and develops ICT applications to optimize care processes.

Differentiator

Problem solved

Functional benefit

Products and services

  • ADHDcentraal Knowledge and treatment center for ADHD in adults, providing specialized psychiatric care, diagnosis, and treatment services. Targets adult patients seeking ADHD assessment and ongoing care, with combined in-person and video consultation options.
  • ADHDcentraal Jeugd Knowledge and treatment center for AD(H)D in children and adolescents, offering specialized youth mental health services with family-centered care and combined consultation options to minimize disruption.
  • WPEX Provides psychiatric, neuropsychological, and insurance medical expert examinations for employers, occupational health services, and insurance companies. Supports objective expert assessments required for occupational health decisions and insurance claims.
  • QSG Provides diagnosis, treatment, and reintegration services for employees with psychological absenteeism under ARBO (occupational health) frameworks. Helps employers reduce absenteeism costs and comply with occupational health regulations.
  • The Brain Hub Helps employees with neurodivergent brains excel by guiding organizations through transformation toward a healthy and inclusive work environment. Provides consulting on organizational change, neurodivergent employee retention, and inclusive workplace culture.

Quantifiable outcome

  • Minimized patient wait times

Companies that use Dedimo

Customer profile

Segments5 records

Ideal customer profiles5 records

Dedimo technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Dedimo partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Institutions and Universities (unnamed)minorStrategic or Co-development PartnerDedimo R&D collaborates with external institutions and universities on research projects, supporting the individual subsidiaries' research objectives and contributing to product development. Specific partner names and dates are not publicly disclosed.

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

Dedimo competitors and assessment

Company assessment

Others

  • Karify: Dutch digital mental health platform providing e-mental health tools and patient-clinician portals to GGZ providers. Comparable to Dedimo R&D's custom ICT applications and Dedimo's broader digital health tooling strategy, as an enabling technology peer rather than direct clinical competitor.

Broad incumbents

  • ArboNed: Largest Dutch ARBO/occupational health service provider, part of HumanTotalCare. Directly comparable to Dedimo's QSG psychological absenteeism reintegration and The Brain Hub workplace neurodiversity consulting via the same employer/ARBO channel.
  • PsyQ: Largest Dutch chain of mental healthcare clinics, part of Parnassia Groep, offering specialized outpatient GGZ across multiple conditions. Comparable to Dedimo as a Netherlands-based specialty mental healthcare operator, though with broader condition coverage and larger scale.
  • Headspace Health: Global digital mental health platform combining meditation, coaching and therapy. Comparable to Dedimo's employer-facing The Brain Hub and broader mental healthcare portfolio, though at much larger scale and B2B employer-first go-to-market.

Emerging players

  • Talkspace: US telehealth platform offering therapy and psychiatry via video/text to insurers and employers. Comparable to Dedimo's hybrid mental healthcare delivery model and payer-channel revenue structure, though operating in the US market.
  • OpenUp: European digital mental health platform serving employers and employees across multiple countries. Comparable to Dedimo's The Brain Hub B2B employer channel and ADHDcentraal's digital-first delivery model, though operating pan-Europe rather than Netherlands-only.
  • Lyra Health: US mental health benefits platform for employers offering therapy, coaching and psychiatry. Comparable to Dedimo's The Brain Hub and QSG B2B employer services targeting workplace mental health and absenteeism reduction.

Direct peers

  • Interapy: Dutch online therapy provider offering reimbursed mental healthcare through internet-based protocols. Comparable to Dedimo's ADHDcentraal and QSG lines via the same Dutch health-insurance reimbursement channel and behavioral therapy focus.
  • Mindler: Swedish-founded digital mental health platform that operates in the Netherlands, offering video-based therapy and psychiatry with insurance reimbursement. Directly comparable to Dedimo's hybrid in-person + video mental health delivery model.
  • iPractice: Dutch psychology practice network offering online and in-person mental healthcare reimbursed by Dutch insurers. Comparable to ADHDcentraal and ADHDcentraal Jeugd as a reimbursed outpatient mental healthcare provider in the Netherlands.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Dedimo social profiles

Digital presence

Dedimo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dedimo leadership team

Management profile

Number of profiles

Profiles8 records

Dedimo subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Dedimo funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dedimo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dedimo

What does Dedimo do?

Dedimo is a Dutch healthcare innovation company operating a portfolio of five specialized mental healthcare subsidiaries: ADHDcentraal (adult ADHD diagnosis and treatment), ADHDcentraal Jeugd (youth ADHD diagnosis and treatment), WPEX (psychiatric neuropsychological and insurance medical expert examinations), QSG (diagnosis, treatment and reintegration for psychological absenteeism under ARBO frameworks), and The Brain Hub (neurodivergent workplace transformation consulting). Services are delivered through specialized clinics supported by a central staff providing HR, finance, ICT, marketing, data science, and R&D functions.

Is Dedimo a public or private company?

Dedimo is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Dedimo founded?

Dedimo was founded in 2020. It employs 11 to 50 people.

Where is Dedimo based?

Dedimo is headquartered in Utrecht, Netherlands, in the Europe region.

How does Dedimo make money?

One revenue line is on record: mental Healthcare Services Revenue.

Who are Dedimo's main competitors?

Karify is listed as an others. Broad incumbents are ArboNed, PsyQ and Headspace Health. Emerging players are Talkspace, OpenUp and Lyra Health. Direct peers are Interapy, Mindler and iPractice.

Does Dedimo have an API?

No public API is recorded for Dedimo.

What industry is Dedimo in?

Dedimo's product category is Mental Healthcare Services. Its primary akta.pro industry code is HLALAEAJ, Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching), with a secondary code of HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 621112 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales